Dr. Jeffrey S Smith , DO
General Practice • Waynesburg, PA
734 E High St
Waynesburg, PA 153701710
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Jeffrey Smith is listed in NPPES under General Practice.
-
NPI assigned on October 3, 2005; this date does not establish years in practice.
-
Published CMS data list 207 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 99308 — Subsequent nursing facility care with straightforward level of medical decision making, per day: 207 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 9,468 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 724 prescription fills, including refills.
- Furosemide — 425 prescription fills, including refills.
- Lisinopril — 399 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 99 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 95% of clinicians listed under General Practice in Pennsylvania (2024, 81 clinicians with data). Median for this group: 358. Middle half: 43 to 1,907.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 684 in 2019 to 207 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
734 E High St
Waynesburg, PA 153701710
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $14,751 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $11,753 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
9,470 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$267,449 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2020
All general payments: $134.75 across 9 records.
By nature of payment
- Food and Beverage: $134.75 across 9 records.
Reporting-company totals (3 largest of 5)
- Boehringer Ingelheim Pharmaceuticals, Inc.: $38.94 across 3 records.
- AstraZeneca Pharmaceuticals LP: $33.63 across 2 records.
- Janssen Pharmaceuticals, Inc: $28.44 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2020 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Smith has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Smith as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Waynesburg and Pennsylvania
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under General Practice in Pennsylvania (2024, 81 clinicians with data). Median for this group: 358. Middle half: 43 to 1,907.
Too few clinicians listed under General Practice in Waynesburg have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under General Practice in Pennsylvania (2024, 81 clinicians with data). Median for this group: $19,056. Middle half: $590 to $143,091.
Too few clinicians listed under General Practice in Waynesburg have Medicare Part D data for 2024 to compare.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Smith are from 2023.
3 active clinicians are listed under General Practice with a practice address in Waynesburg, PA (345 in Pennsylvania).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 70% from 684 in 2019 to 207 in 2023.
- 2019: 684
- 2020: 486
- 2021: 339
- 2022: 254
- 2023: 207
-
Medicare-allowed amount
Medicare-allowed amount decreased 71% from $51,704 in 2019 to $14,751 in 2023.
- 2019: $51,704
- 2020: $38,473
- 2021: $29,655
- 2022: $18,800
- 2023: $14,751
-
Paid by Medicare
Paid by Medicare decreased 66% from $34,730 in 2019 to $11,753 in 2023.
- 2019: $34,730
- 2020: $26,394
- 2021: $18,420
- 2022: $14,951
- 2023: $11,753
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 38% from 15,367 in 2020 to 9,468 in 2024.
- 2020: 15,367
- 2021: 12,880
- 2022: 10,176
- 2023: 13,420
- 2024: 9,468
-
30-day fills
30-day fills decreased 59% from 22,925 in 2020 to 9,470 in 2024.
- 2020: 22,925
- 2021: 20,050
- 2022: 11,620
- 2023: 13,420
- 2024: 9,470
-
Part D drug cost
Part D drug cost decreased 83% from $1,549,879 in 2020 to $267,449 in 2024.
- 2020: $1,549,879
- 2021: $1,493,329
- 2022: $550,814
- 2023: $525,725
- 2024: $267,449
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $667.72 in 2019 to $134.75 in 2020.
- 2019: $667.72
- 2020: $134.75
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2020), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2020 (payments made January 1 – December 31, 2020): fewer than 11 records totaling $134.75.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $18.41 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $17.59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
STIOLTO RESPIMAT | General | $16.27 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $16.04 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
XTAMPZA | General | $15.33 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
XARELTO | General | $14.43 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
XARELTO | General | $14.01 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
TRADJENTA | General | $11.63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
STIOLTO RESPIMAT | General | $11.04 |
Source: CMS Open Payments, program year 2020, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99308
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more
|
207 | 24 | $148.19 | $71.26 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 724 | 5,059 | $4,803.92 | 17 |
| Furosemide | Furosemide | 425 | 3,089 | $1,491.64 | 14 |
| Lisinopril | Lisinopril | 399 | 2,919 | $1,519.28 | 13 |
| Levothyroxine Sodium | Levothyroxine Sodium | 329 | 2,310 | $1,702.95 | — |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 303 | 2,118 | $2,136.41 | — |
| Amlodipine Besylate | Amlodipine Besylate | 285 | 2,002 | $1,243.35 | — |
| Metoprolol Tartrate | Metoprolol Tartrate | 278 | 1,942 | $1,077.34 | — |
| Metformin Hcl | Metformin Hcl | 265 | 1,839 | $1,001.23 | — |
| Farxiga | Dapagliflozin Propanediol | 250 | 1,750 | $36,258.66 | — |
| Eliquis | Apixaban | 248 | 1,736 | $36,717.69 | — |
| Escitalopram Oxalate | Escitalopram Oxalate | 228 | 1,596 | $1,282.84 | — |
| Gabapentin | Gabapentin | 225 | 1,575 | $1,088.09 | — |
| Metoprolol Succinate | Metoprolol Succinate | 220 | 1,536 | $1,709.27 | — |
| Sertraline Hcl | Sertraline Hcl | 208 | 1,439 | $997.16 | — |
| Losartan Potassium | Losartan Potassium | 206 | 1,438 | $933.73 | — |
| Donepezil Hcl | Donepezil Hcl | 201 | 1,407 | $1,075.17 | — |
| Trazodone Hcl | Trazodone Hcl | 201 | 1,410 | $668.39 | — |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 198 | 1,386 | $2,259.75 | — |
| Digoxin | Digoxin | 162 | 1,134 | $1,506.64 | — |
| Potassium Chloride | Potassium Chloride | 162 | 1,263 | $964.94 | — |
| Tamsulosin Hcl | Tamsulosin Hcl | 159 | 1,178 | $990.41 | — |
| Divalproex Sodium | Divalproex Sodium | 157 | 1,099 | $3,958.97 | — |
| Duloxetine Hcl | Duloxetine Hcl | 155 | 1,081 | $3,179.21 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 125 | 871 | $635.02 | — |
| Mirtazapine | Mirtazapine | 121 | 847 | $693.86 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20120109000716
PA
2365618659
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated October 03, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Mailing Address
734 E High St
Waynesburg, PA 153701710
Phone: 7248522050